Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open‐Label Trial
暂无分享,去创建一个
E. Martı́n-Mola | D. Veale | J. Fonseca | R. Sanmartí | Carlos M González | A. Escudero-Contreras | L. Ercole | Rocío Alonso